Membrane fusion during HSV-1 entry
HSV-1 进入期间的膜融合
基本信息
- 批准号:7843510
- 负责人:
- 金额:$ 7.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-15 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressBindingCell fusionCell membraneCell surfaceCellsDataEndocytosisEndosomesEventGlycoproteinsGoalsHerpesviridaeHerpesvirus 1Lipid BilayersLocationMeasuresMediatingMembraneMembrane FusionMethodsModelingMolecularProcessProteinsResearchRouteSimplexvirusSiteTestingVirusdesigninhibitor/antagonistlate endosomenovelpublic health relevancereceptor bindingreceptor mediated endocytosisresearch study
项目摘要
DESCRIPTION (provided by applicant): Herpes simplex virus (HSV), and likely all herpesviruses, use two methods to enter cells: (1) direct fusion: the virus fuses its lipid bilayer with the plasma membrane at the cell surface and (2) receptor-mediated endocytosis (RME): the virus fuses with an endosomal membrane after endocytosis and a reduction in pH. Our long-term goal is to understand the molecular events occurring during HSV-1-induced membrane fusion for both direct fusion and RME. We have recently identified a fusion intermediate (hemifusion) during virus-to- cell fusion for HSV-1. This is the first description of a fusion intermediate for any herpesvirus or any virus that uses more than two proteins to mediate membrane fusion. Our preliminary data are consistent with hemifusion occurring at the cell surface in cells that require endocytosis and low pH for HSV-1 entry. The focus of this application is to examine membrane fusion in our newly proposed model for herpesvirus RME. A unique aspect of this model is the proposed cell-surface location of the hemifusion event. We outline experiments here to establish the cellular location of hemifusion during HSV-1 RME by co- localizing the site of hemifusion with cellular markers. We will also use pharmacological agents that block endocytosis and endosomal pH reduction to determine if those processes are required for hemifusion to occur. Because herpesvirus entry occurs at the cell surface at neutral pH and is postulated to occur at the low pH of a late endosome, a testable prediction is that the HSV-1 fusion machinery must function at both neutral and low pH. To test that prediction, we will examine HSV-1 membrane fusion at low pH and compare it to that at neutral pH. The results obtained from this application will establish a model for HSV-1 RME. A detailed understanding of membrane fusion induced during direct fusion and RME is necessary to facilitate the design of inhibitors to block hemifusion, full fusion, and virus spread.
PUBLIC HEALTH RELEVANCE: The aim of this project is to characterize the membrane fusion events during herpes simplex virus type 1 (HSV-1) entry into cells via receptor-mediated endocytosis. HSV-1 enters cells by multiple routes so the intricate understanding of the mechanism of each route is required to facilitate the design of anti-virals to block virus entry and spread.
描述(由申请人提供):单纯疱疹病毒(HSV)和可能所有的疱疹病毒,使用两种方法进入细胞:(1)直接融合:病毒将其脂质双分子层与细胞表面的质膜融合;(2)受体介导的内吞作用(RME):病毒在内吞作用和ph降低后与内体膜融合。我们的长期目标是了解HSV-1诱导的膜融合过程中发生的分子事件,包括直接融合和RME。我们最近发现了HSV-1病毒与细胞融合过程中的融合中间体(半融合)。这是首次描述任何疱疹病毒或任何使用两种以上蛋白质介导膜融合的病毒的融合中间体。我们的初步数据与在需要内吞作用和低pH值以供HSV-1进入的细胞表面发生的半灌注一致。本应用的重点是在我们新提出的疱疹病毒RME模型中检查膜融合。该模型的一个独特方面是提出的半灌注事件的细胞表面位置。我们在这里概述了通过与细胞标记物共同定位半融合部位来确定HSV-1 RME期间半融合的细胞位置的实验。我们还将使用阻断内吞作用和内体pH值降低的药物来确定这些过程是否需要发生半灌注。由于疱疹病毒在中性pH下发生在细胞表面,并且假定在后期内体的低pH下发生,一个可测试的预测是,HSV-1融合机制必须在中性和低pH下都起作用。为了验证这一预测,我们将检查低pH下的HSV-1膜融合,并将其与中性pH下的融合进行比较。从这个应用中获得的结果将建立HSV-1 RME模型。详细了解直接融合和RME过程中诱导的膜融合对于设计阻断半融合、完全融合和病毒传播的抑制剂是必要的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert James Geraghty其他文献
Robert James Geraghty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert James Geraghty', 18)}}的其他基金
Discovery and development of novel anti-HCMV agents targeting the UL89 terminase protein
发现和开发针对 UL89 终止酶蛋白的新型抗 HCMV 药物
- 批准号:
10318943 - 财政年份:2019
- 资助金额:
$ 7.55万 - 项目类别:
Discovery and development of novel anti-HCMV agents targeting the UL89 terminase protein
发现和开发针对 UL89 终止酶蛋白的新型抗 HCMV 药物
- 批准号:
10534193 - 财政年份:2019
- 资助金额:
$ 7.55万 - 项目类别:
Spread of HSV-1 mediated by the gD receptor nectin-1
gD 受体 nectin-1 介导的 HSV-1 传播
- 批准号:
6667357 - 财政年份:2002
- 资助金额:
$ 7.55万 - 项目类别:
Spread of HSV-1 mediated by the gD receptor nectin-1
gD 受体 nectin-1 介导的 HSV-1 传播
- 批准号:
6706949 - 财政年份:2002
- 资助金额:
$ 7.55万 - 项目类别:
Spread of HSV-1 mediated by the gD receptor nectin-1
gD 受体 nectin-1 介导的 HSV-1 传播
- 批准号:
6860144 - 财政年份:2002
- 资助金额:
$ 7.55万 - 项目类别:
Spread of HSV-1 mediated by the gD receptor nectin-1
gD 受体 nectin-1 介导的 HSV-1 传播
- 批准号:
7031532 - 财政年份:2002
- 资助金额:
$ 7.55万 - 项目类别:
Spread of HSV-1 mediated by the gD receptor nectin-1
gD 受体 nectin-1 介导的 HSV-1 传播
- 批准号:
6461587 - 财政年份:2002
- 资助金额:
$ 7.55万 - 项目类别:
PROTEIN INTERACTIONS IN HERPESVIRUS CELL FUSION
疱疹病毒细胞融合中的蛋白质相互作用
- 批准号:
2671615 - 财政年份:1998
- 资助金额:
$ 7.55万 - 项目类别:
PROTEIN INTERACTIONS IN HERPESVIRUS CELL FUSION
疱疹病毒细胞融合中的蛋白质相互作用
- 批准号:
2643308 - 财政年份:1997
- 资助金额:
$ 7.55万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Continuing Grant
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Discovery Projects
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Fellowship
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Research Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Standard Grant
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Standard Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Discovery Projects
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Research Grant